Jedd D. Wolchok
0000-0001-6718-2222
Publication & Citation Trends
Publications
0 total
Reduced IL-2 Intensity Is Associated with Improved Outcomes in Tumor-Infiltrating Lymphocyte Therapy: A Meta-Analysis
Cited by 0
Semantic Scholar
INTRAVESICAL MUC16 TARGETING CAR T CELLS FOR ORGAN-CONFINED BLADDER CANCERS
Cited by 1
Semantic Scholar
IMMU-72. Locoregionally delivered PD-1 blockade augments B7-H3 targeting CAR T cell efficacy in models of glioblastoma
Cited by 0
Semantic Scholar
150 The Role of Neutrophils in Cutaneous Immune-Related Adverse Events: A Case of Bullous Pemphigoid in a Patient Undergoing Immunotherapy
Cited by 0
Semantic Scholar
Abstract B017: Novel mesothelin-based CAR T cells targeting MUC16 as an intravesical bladder cancer therapy
Cited by 0
Semantic Scholar
RECISTv1.1 progression in oncology: Shades of gray. OA
Cited by 11
Semantic Scholar
Abstract 3468: Immunoproteasome expression and checkpoint blockade response in advanced non-small cell lung cancer
Cited by 0
Semantic Scholar
CTIM-18. NRG ONCOLOGY STUDY BN007: RANDOMIZED PHASE II/III TRIAL OF IPILIMIUMAB (IPI) PLUS NIVOLUMAB (NIVO) VS. TEMOZOLOMIDE (TMZ) IN MGMT-UNMETHYLATED (UMGMT) NEWLY DIAGNOSED GLIOBLASTOMA (NGBM) OA
Cited by 1
Semantic Scholar
Research Topics
Cancer Immunotherapy and Biomarkers
(719)
Immunotherapy and Immune Responses
(507)
CAR-T cell therapy research
(439)
Melanoma and MAPK Pathways
(201)
Immune Cell Function and Interaction
(139)
Affiliations
Université Claude Bernard Lyon 1
Université Paris-Sud
Thiel College
University of Toledo Medical Center
West Virginia University